Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Cochlear Implantation in Charcot-Marie-Tooth Disease: Case Report and Review of the Literature
Anzalone, C. Lane , Nuhanovic, Sarah, Olund, Amy P., Carlson, Matthew L.

Mayo Clinic

Case Reports in Medicine | March 26, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-3

10.1155/2018/1760978 | PMID 29780422 Get It

Introduction. Charcot-Marie-Tooth (CMT) disease is a peripheral hereditary neuropathy associated with motor and sensory impairment and can result in profound sensorineural hearing loss (SNHL). Currently, the role of cochlear implantation in the setting of CMT and other progressive peripheral neurodegenerative disorders is not well established. Methods. Case report and review of the English literature. Results. A 70-year-old male with CMT was referred for evaluation of progressive asymmetric SNHL and reported a 15-year duration of deafness involving the left ear. Audiometric testing confirmed profound SNHL in the left ear, while the right ear exhibited moderate-to-severe SNHL. Left-sided cochlear implantation was performed using a conventional length lateral wall electrode. Intraoperative device testing found normal impedance levels throughout the array; however, electrically evoked auditory potentials were absent on all electrodes. Upon initial activation 3 weeks after surgery, the patient reported excellent access to sound in the cochlear implant-only condition. He has made good progress at each subsequent visit; speech perception testing after seven months showed improvement from 0% to 32% on AzBio sentence and 53% on CNC phoneme testing in the cochlear implant-only condition. Conclusion. We report the third case of cochlear implantation in a patient with CMT. SNHL in CMT is hypothesized to result from disruption of synchronous activity of the cochlear nerve. In patients with CMT, cochlear implantation may reconstitute synchronous neural activity by way of supraphysiological electrical stimulation. Our results corroborate two earlier reports that cochlear implantation is a viable option for rehabilitation of SNHL in this unique subset of patients.
Recurrent GNA 14 mutations in anastomosing haemangiomas
Bean, Gregory R. , Joseph, Nancy M. , Folpe, Andrew L. , Horvai, Andrew , Umetsu, Sarah E.

Mayo Clinic

Histopathology | March 25, 2018 | Volume: 73 | Issue: 2 | Pages: 354-357

10.1111/his.13519 | PMID 29574926 Get It

A rapid and reliable chromosome analysis method for products of conception using interphase nuclei
Babu, Ramesh , Dyke, Daniel L. Van , Bhattacharya, Saurabh Kumar , Dev, Vaithilingam G., Liu, Mingya, Kwon, Minjae, Gu, Guangyu , Koduru, Prasad , Rao, Nagesh, Williamson, Cynthia M., Fuentes, Sarah, Papa, Stephen, Kopuri, Srikanthi, Lal, Vandana , Van Dyke, Daniel L, Williamson, Cynthia, Fuentes, Ernesto J.

Mayo Clinic

Molecular Genetics & Genomic Medicine | March 24, 2018 | Volume: 6 | Issue: 3 | Pages: 370-381

10.1002/mgg3.381 | PMID 29573570 Get It

AbstractBackgroundKaryotype determination has a central role in the genetic workup of pregnancy loss, as aneuploidy (trisomy and monosomy) and polyploidy (triploidy and tetraploidy) are the cause in at least 50% of first trimester, 25% of second trimester, and 11% of third trimester miscarriages. There are several limitations with the current approaches of obtaining a karyotype using traditional cytogenetics, fluorescence in situ hybridization with a limited number of probes, and chromosomal microarray. These include culture failure, incomplete results, lower sensitivity, and longer reporting time.MethodsTo overcome current limitations, a novel molecular assay is developed with a Standard Resolution Interphase Chromosome Profiling probe set which is a variation of the recently developed High Resolution probe set. It generates a molecular karyotype that can detect all major changes commonly associated with pregnancy loss. Initial familiarization of signal patterns from the probe set was used, followed by validation of the method using 83 samples from miscarriages in a blind study from three different laboratories. Finally, the clinical utility of the method was tested on 291 clinical samples in two commercial reference laboratory settings on two different continents.ResultsThe new molecular approach not only identified all the chromosome changes observed by current methods, but also significantly improved abnormality detection by characterizing derivative chromosomes and finding subtle subtelomeric rearrangements, balanced and unbalanced. All Robertsonian translocations were also detected. The abnormality rate was 54% on clinical samples from commercial laboratory 1 and 63% from laboratory 2.ConclusionThe attributes of this method make it an ideal choice for the genetic workup of miscarriages, namely (1) near 100% successful results, (2) greater sensitivity than conventional chromosome analysis or FISH panels, (3) rapid reporting time, and (4) favorable comparisons with chromosomal microarray.
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology
Vidal, Claudia I. , Armbrect, Eric A., Andea, Aleodor A. , Bohlke, Angela, Comfere, Nneka I. , Hughes, Sarah , Kim, Jinah , Kozel, Jessica A. , Lee, Jason B. , Linos, Konstantinos , Litzner, Brandon R. , Missall, Tricia A. , Sundram, Uma , Swick, Brian L. , Hurley, M. Yadira , Alam, Murad , Argényi, Zsolt B., Duncan, Lyn M., Elston, Dirk M. , Emanuel, Patrick O. , Ferringer, Tammie , Fung, Maxwell A. , Hosler, Gregory A. , Lazar, Alexander J. , Prieto, Víctor G. , Schaffer, András , Subtil, Antonio , Wang, Wei‐Lien , Sundram, Uma , Hurley, Maria Yadira , Emanuel, Patrick O , Fung, Maxwell A , Hosler, Gregory A , Lazar, Alexander J , Vidal, Claudia I , Kim, Jinah , Linos, Konstantinos , Missall, Tricia A , Novoa, Roberto A. , Alam, Murad , Lowe, Lori , Plaza, Jose Antonio , Robinson, June K.

Mayo Clinic

Journal of Cutaneous Pathology | March 22, 2018 | Volume: 45 | Issue: 8 | Pages: 563-580

10.1111/cup.13142 | PMID 29566273 Get It

BackgroundAppropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision‐making.ObjectivesThe American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology.MethodsThe RAND/UCLA appropriateness methodology, which combines evidence‐based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology.ResultsWith the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate,” 52 (25%) “rarely appropriate” and 43 (20%) “uncertain appropriateness.”LimitationsThe methodology requires a focus on appropriateness without comparison between tests and irrespective of cost.ConclusionsThe ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.
A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations
Schiariti, Verónica , Fowler, Eileen , Brandenburg, Joline E. , Levey, Eric, McIntyre, Sarah , Sukal‐Moulton, Theresa , Ramey, Sharon Landesman , Rose, Jessica , Sienko, Susan , Stashinko, Elaine, Feldman, Robin , Koenig, James I. , Feldman, Robin S , Koenig, James I , Vogtle, Laura K.

Mayo Clinic

Developmental Medicine & Child Neurology | March 15, 2018 | Volume: 60 | Issue: 10 | Pages: 976-986

10.1111/dmcn.13723 | PMID 29542813 Get It

To increase the efficiency and effectiveness of clinical research studies, cerebral palsy (CP) specific Common Data Elements (CDEs) were developed through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Academy of Cerebral Palsy and Developmental Medicine (AACPDM). International experts reviewed existing NINDS CDEs and tools used in studies of children and young people with CP. CDEs were compiled, subjected to internal review, and posted online for external public comment in September 2016. Guided by the International Classification of Functioning, Disability and Health framework, CDEs were categorized into six domains: (1) participant characteristics; (2) health, growth, and genetics; (3) neuroimaging; (4) neuromotor skills and functional assessments; (5) neurocognitive, social, and emotional assessments; and (6) engagement and quality of life. Version 1.0 of the NINDS/AACPDM CDEs for CP is publicly available on the NINDS CDE and AACPDM websites. Global use of CDEs for CP will standardize data collection, improve data quality, and facilitate comparisons across studies. Ongoing collaboration with international colleagues, industry, and people with CP and their families will provide meaningful feedback and updates as additional evidence is obtained. These CDEs are recommended for NINDS‐funded research for CP.What this paper adds This is the first comprehensive Common Data Elements (CDEs) for children and young people with CP for clinical research. The CDEs for children and young people with CP include common definitions, the standardization of case report forms, and measures. The CDE guides the standardization for data collection and outcome evaluation in all types of studies with children and young people with CP. The CDE ultimately improves data quality and data sharing.
“Keep the faith”: Spirituality as a contributor to resiliency in five elderly people
Sytsma, Terin T. , Schmelkin, Leah A., Jenkins, Sarah M. , Lovejoy, Laura A., Piderman, Katherine M. , Lapid, Maria I.

Mayo Clinic

Journal of Religion, Spirituality & Aging | March 14, 2018 | Volume: 30 | Issue: 4 | Pages: 314-324

10.1080/15528030.2018.1441095 Get It

Inflammatory Myofibroblastic Tumor Associated With the Placenta
Ladwig, Nicholas R. , Schoolmeester, J. Kenneth , Weil, Laura , Zaloudek, Charles , Umetsu, Sarah E. , Chapman, Jocelyn S.

Mayo Clinic

American Journal of Surgical Pathology | March 4, 2018 | Volume: 42 | Issue: 6 | Pages: 807-812

10.1097/pas.0000000000001044 | PMID 29505427 Get It

Inflammatory myofibroblastic tumor (IMT) is a neoplasm of intermediate malignant potential that only rarely involves the gynecologic tract. Several cases of IMT arising in various locations including the lung, bladder, trachea, and breast in association with pregnancy have been reported in the literature, and 3 cases involving the placenta have been previously described. We report 2 cases of IMT identified in association with pregnancy; the first was an intrauterine mass delivered entirely separate from the placenta and fetus, and the second was an incidental mass identified within the placental parenchyma following delivery. Short tandem repeat genotyping was used to compare tissue from the tumor and the placenta for both cases. Both tumors were determined to be of maternal origin, confirming that uterine IMTs may present within the placenta or as a separate mass following delivery. This demonstrates the utility of short tandem repeat genotyping in determining the origin of tumors presenting in association with the placenta.
An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction
Peterson, Sarah J. , Cappola, Anne Rentoumis , Castro, M. Regina , Dayan, Colin , Hennessey, James V. , Kopp, Peter , Ross, Douglas S. , Samuels, Mary H. , Sawka, Anna M. , Taylor, Peter , Jonklaas, Jacqueline , Bianco, Antônio C. , Taylor, Peter N , Farwell, Alan Perry

Mayo Clinic

Thyroid | March 3, 2018 | Volume: 28 | Issue: 6 | Pages: 707-721

10.1089/thy.2017.0681 | PMID 29620972 Get It

Impact of preoperativeBRCA1/2testing on surgical decision making in patients with newly diagnosed breast cancer
Yadav, Siddhartha , Jinna, Sruthi , Pereira-Rodrigues, Otavio, Reeves, Ashley , Campian, Sarah, Sufka, Amy, Zakalik, Dana , Yadav, Siddhartha

Mayo Clinic

The Breast Journal | March 2, 2018 | Volume: 24 | Issue: 4 | Pages: 541-548

10.1111/tbj.13007 | PMID 29498445 Get It

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study
Mathis, Kellie L. , Tse, Chung Sang , Pembérton, John H., Shen, Bo , Kochhar, Gursimran , Singh, Amandeep , Dulai, Parambir S. , Eisenstein, Samuel , Sandborn, William J. , Parry, Lisa, Stringfield, Sarah , Hudesman, David , Remzi, Feza H. , Loftus, Edward V. , Tse, C S , Loftus, Edward V , Lightner, Amy L.

Mayo Clinic

Inflammatory Bowel Diseases | March 2, 2018 | Volume: 24 | Issue: 4 | Pages: 871-876

10.1093/ibd/izx076 | PMID 29509927 Get It